The concept being tested is bistability created by mutual repression. A synthetic toggle switch uses two transcriptional repressors that inhibit each other’s expression. This reciprocal repression forms two stable states: one where the first gene is on and the second is off, and another where the second gene is on and the first is off. Because the system has two stable equilibria, it can “sit” in either state until a sufficiently strong input shifts it to the other, effectively toggling between states. This architecture relies on strong, cooperative repression to create distinct, enduring states. If two genes were simply mutually activating, you’d tend toward runaway expression rather than stable toggling. An oscillator usually needs a time delay and a particular feedback arrangement to produce periodic cycling, not just two stable states. And a circuit that permanently expresses a single gene doesn’t provide a switch between alternative states. So the description with mutual repression leading to two stable expression patterns best captures a toggle switch.

Biotechnology uses living systems to produce useful products. Producing insulin in bacteria is a classic example because it shows turning a simple organism into a production factory for a human protein through genetic engineering. By inserting the human insulin gene into bacterial cells, these cells express and secrete insulin that can be harvested and purified for medical use. This illustrates how living systems are harnessed and manipulated at the molecular level to create therapeutics, a hallmark of biotechnology. The other options fall SAMPLEoutside this approach: synthesizing aspirin chemically relies on non-biological chemical reactions; physical filtration and mechanical chopping are purely physical processes and do not involve using living organisms or genetic manipulation.

Telomeres act as protective caps at chromosome ends and are shortened with each round of DNA replication due to the end-replication problem. Telomerase is a reverse transcriptase that carries its own RNA template and uses it to add telomeric repeats to the 3’ end of telomeres, effectively lengthening them. In most somatic cells, telomerase is not active, so each cell division leaves the telomeres a bit shorter. When telomeres become critically short, the cell detects DNA damage and halts division or undergoes programmed cell death, a process called replicative senescence. This limits the number of times somatic cells can divide and helps prevent genomic instability. The statement is correct because it accurately describes both the enzyme’s action—extending telomeres using its RNA template—and the typical somatic-cell situation—lack of telomerase leading to progressive telomere shortening and eventual senescence.

Genetic code degeneracy means different codons can code for the same amino acid. A silent mutation is a DNA base change that produces a codon still encoding the same amino acid, so the resulting protein sequence stays the same. For example, a codon change from GGU to GGC both specify glycine, so the amino acid sequence is unchanged. While the protein composition remains identical, silent mutations can sometimes affect gene expression details like mRNA structure or splicing in certain contexts, but the amino acid sequence remains unaffected. In contrast, a missense mutation changes a codon to one that encodes a different amino acid, altering the protein sequence. A nonsense mutation turns a codon into a stop signal, truncating the protein. A frameshift mutation inserts or deletes nucleotides not in multiples of three, shifting the entire downstream reading frame and usually producing a markedly different, often nonfunctional protein.